コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ific and clinical position of cardiovascular regenerative therapy.
2 ell type for potential use in cardiovascular regenerative therapy.
3 s should be done before they can be used for regenerative therapy.
4 ing human cardiac development as well as for regenerative therapy.
5 rug discovery, disease modeling, and cardiac regenerative therapy.
6 l stem cells hold promise for cardiovascular regenerative therapy.
7 is may enhance cardiac-progenitor cell-based regenerative therapy.
8 ssociated with GCA and no previous report of regenerative therapy.
9 polysaccharide-mediated bone resorption) and regenerative therapy.
10 onarily conserved and could be exploited for regenerative therapy.
11 1 and 2 mobility, will respond favorably to regenerative therapy.
12 s provide an excellent pool of molecules for regenerative therapy.
13 control the clinical outcomes of periodontal regenerative therapy.
14 ally provide a limitless source of cells for regenerative therapy.
15 s may be significant in clinical outcomes of regenerative therapy.
16 ould provide a promising source of cells for regenerative therapy.
17 istic effect of EMPs and BPBM in periodontal regenerative therapy.
18 for significant clinical improvements after regenerative therapy.
19 and are therefore not a promising target for regenerative therapy.
20 edures is an important aspect of periodontal regenerative therapy.
21 ow this occurs is highly relevant to cardiac regenerative therapy.
22 defects may be successfully treated with non-regenerative therapy.
23 promising approach to expand stem cells for regenerative therapy.
24 stering the path to novel approaches in bone-regenerative therapy.
25 -HS may expand KIT+ progenitors in vitro for regenerative therapy.
26 challenges of this new technology for future regenerative therapy.
27 er injury and discuss their implications for regenerative therapy.
28 o provide a novel route for cardiac cellular regenerative therapy.
29 rogenitor cells are an attractive target for regenerative therapy.
30 this promising new technology into a proven regenerative therapy.
31 hat has dramatic implications for cell-based regenerative therapies.
32 eld potential new targets and strategies for regenerative therapies.
33 cells in mammals and developing novel renal regenerative therapies.
34 ssues and the potential effectiveness of new regenerative therapies.
35 ypes and hence have tremendous potential for regenerative therapies.
36 nd aid in the development of stem cell-based regenerative therapies.
37 tracer reporter probes for tracking cellular regenerative therapies.
38 ices to promote vascularization for directed regenerative therapies.
39 al elements when designing human tissues for regenerative therapies.
40 INFUSE bone grafts for periodontal and oral regenerative therapies.
41 tor cells with the potential for safe use in regenerative therapies.
42 nal stem cells can be activated for possible regenerative therapies.
43 iation that makes them potential targets for regenerative therapies.
44 of targeted strategies that expand HSCs for regenerative therapies.
45 erable for assessing efficacy of periodontal regenerative therapies.
46 ontained versus non-contained, using various regenerative therapies.
47 of factors involved in designing predictable regenerative therapies.
48 ort superiority or equivalency between the 2 regenerative therapies.
49 bioactive agents is important for improving regenerative therapies.
50 estoration of beta-cells is a major goal for regenerative therapies.
51 ap, hemisection, tunneling or extraction, to regenerative therapies.
52 ion of functional vision through optic nerve regenerative therapies.
53 may improve the efficacy of stem-cell-based regenerative therapies.
54 ls (HSCs) are essential for many life-saving regenerative therapies.
55 nitely, making them an attractive source for regenerative therapies.
56 defects may be treated predictably with non-regenerative therapies.
57 ate MSC population for designing predictable regenerative therapies.
58 monitor the fate and action of cells used in regenerative therapies.
59 drug toxicology tests, and advance potential regenerative therapies.
60 ns critical for the development of potential regenerative therapies.
61 ration, and therefore they could be used for regenerative therapies.
62 novel perspective for reinterpreting cardiac regenerative therapies.
63 c cell types for basic laboratory studies or regenerative therapies.
64 ent stem cells will form the basis of future regenerative therapies.
65 cal use could be considered for craniofacial regenerative therapies.
66 ssary for the design of improved periodontal regenerative therapies.
67 ecular materials a great platform to develop regenerative therapies.
68 ces for improving stem cell fate in clinical regenerative therapies.
69 xtensively used to enhance tissue repair and regenerative therapies.
70 scovery of stem cell therapeutics to support regenerative therapies.
71 the heart spurred enthusiasm for cell-based regenerative therapies.
72 this ability may provide insights into human regenerative therapies.
73 ures and have implications for other bladder regenerative therapies.
74 us for exploring mechanobiology paradigms in regenerative therapies.
75 epresents an important step toward potential regenerative therapies.
76 wth potential is of broad interest for tooth regenerative therapies.
77 greatly aid in the development of effective regenerative therapies.
78 ation, basic developmental studies or future regenerative therapies.
79 d highlights pathways for the development of regenerative therapies.
80 repair and is therefore a primary target of regenerative therapies.
81 st that BTC could be a good candidate to aid regenerative therapies.
82 , which supports the relevance of exploring 'regenerative' therapies.
83 harmacodynamic implications in the design of regenerative therapies aimed at increasing beta-cell rep
86 or the widely anticipated next generation of regenerative therapies and as such are pioneering the st
87 s for the treatment of furcation defects via regenerative therapies and the conduction of future stud
88 a conscious approach to the development of a regenerative therapy and, by deciphering the thread conn
90 subgingival microbiota was examined prior to regenerative therapy, and the membrane microbiota was ex
93 inoglycans (GAGs) offer exciting options for regenerative therapies as they allow for the electrostat
94 eview of all pertinent literature discussing regenerative therapy at the time of tooth extraction or
95 cells (hDPSCs) are attractive candidates for regenerative therapy because they can be easily expanded
96 ell-derived progenitors offers potential for regenerative therapies but is often limited by developme
97 ure-induced injury may help to advance brain regenerative therapies by using either transplanted or e
100 mising tool for human developmental biology, regenerative therapies, disease modeling, and drug disco
101 lls (hiPSCs) are a robust source for cardiac regenerative therapy due to their potential to support a
102 ical Wnt signaling as a potential target for regenerative therapies for APAP-induced acute liver fail
107 mation that is crucial to the development of regenerative therapies for human tissues and organs.
112 senescent hCPCs will improve the outcome of regenerative therapy for a substantial patient populatio
114 To improve the efficacy and outcomes of regenerative therapy for furcation defects, the use of p
116 rane for guided tissue regeneration (GTR) as regenerative therapy for intrabony defects in humans and
117 hment gain, and defect fill when employed as regenerative therapy for intraosseous lesions in humans.
120 e conclusions regarding the effectiveness of regenerative therapy for the treatment of furcation defe
121 neration after the application of a combined regenerative therapy for the treatment of maxillary faci
122 ed since the first successful application of regenerative therapy for treatment of periodontal diseas
124 em/progenitor cells hold great potential for regenerative therapies; however, the mechanisms regulati
126 n myelin development and their potential for regenerative therapies in multiple sclerosis and dysmyel
128 s to be a useful and beneficial material for regenerative therapy in Class II furcation type periodon
129 long-term (2 to 5 year) clinical results of regenerative therapy in clinical private practice using
133 ogenitor cells (CPCs) is being evaluated for regenerative therapy in older patients with ischaemic he
142 he available evidence, it was concluded that regenerative therapy is a viable option to achieve predi
143 still needed to determine whether stem cell regenerative therapy is an effective treatment strategy
144 In order to design predictable periodontal regenerative therapies, it is important to understand th
148 l-mediated healing processes have made these regenerative therapies more clinically viable and will c
150 /progenitors have considerable potential for regenerative therapies of liver, bile duct, and pancreat
155 Systemic DOXY, 200 mg/day for 7 days, after regenerative therapy of infrabony defects did not result
158 Early management of intrabony defects with regenerative therapies offers the greatest potential for
159 The clinical selection and application of a regenerative therapy or combination of therapies for per
163 d rational efforts to develop cell-based and regenerative therapies require knowledge of the molecula
164 , as this is a crucial step toward advancing regenerative therapy research for many intractable disor
166 domized controlled clinical trials comparing regenerative therapy (seven DBM, 22 BRG, and 26 GTR) to
168 igenesis and, thus, their implementation for regenerative therapy should be carefully considered in p
170 oratory research such as gene, stem cell, or regenerative therapies targeting congenital or acquired
172 ignificant efforts have been directed toward regenerative therapies that may facilitate neuronal repa
175 lls provides a valuable strategy for cardiac regenerative therapy that avoids the need for preparing
176 hip or sham chip placement one week prior to regenerative therapy that included graft placement and s
177 treatment to other more traditional forms of regenerative therapy to determine its comparative effica
178 o describe the progress in cardiac stem cell regenerative therapy using adult stem cells and to highl
179 caused by periodontitis are often treated by regenerative therapy using autografts and/or allografts.
180 ient received surgical therapy consisting of regenerative therapy using bioactive glass compared to o
182 Within the limitations of the present study, regenerative therapy using either EMD + DBBM or CM + DBB
184 he outcome and predictability of periodontal regenerative therapies, we have focused on determining t
185 em cells are fundamental units for achieving regenerative therapies, which leads naturally to a theor
186 al changes in rat models following localized regenerative therapies, which may not be detected by con
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。